NADAC acquisition cost data for TACLONEX OINTMENT. This is a brand-name medication — generic alternatives may be available at lower prices.
| NDC | NADAC/Unit | Effective Date | Type |
|---|---|---|---|
| 50222022781 | $15.94 | 2021-01-01 | Rx |
| 50222022704 | $18.18 | 2021-01-01 | Rx |
| 50222022781 | $15.94 | 2021-01-01 | Rx |
| 50222022704 | $18.18 | 2021-01-01 | Rx |
Generic: Calcipotriene/Betamethasone | Manufacturer: Overall
| Year | Total Spending | Claims | Beneficiaries | Cost/Unit |
|---|---|---|---|---|
| 2019 | $5.9M | 3,962 | 2,281 | $17.54 |
| 2020 | $2.2M | 1,362 | 739 | $17.94 |
| 2021 | $1.1M | 645 | 284 | $18.74 |
| 2022 | $651.8K | 386 | 143 | $19.34 |
| 2023 | $665.0K | 376 | 138 | $20.52 |
| State | Total Cost | Claims | Beneficiaries |
|---|---|---|---|
| California | $123.7K | 68 | 23 |
| Massachusetts | $97.8K | 39 | 11 |
| New York | $77.9K | 48 | N/A |
| Texas | $50.1K | 23 | N/A |
| Florida | $46.0K | 29 | 12 |
| New Jersey | $37.6K | 18 | N/A |
| North Carolina | $36.4K | 29 | N/A |
| Kansas | $16.8K | 12 | N/A |
| Maryland | $16.1K | 12 | N/A |
| Virginia | $13.9K | 12 | N/A |
The DrugPricePeek editorial team aggregates and verifies drugs data from CMS NADAC & Medicare Part D. Every statistic on this site is cross-referenced against the official source before publication, with quarterly re-verification cycles.
Read our full methodology or contact us with corrections.